This reinforces the need for a CV assessment and surveillance before, during, and after the therapy, a researcher says.

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

An “immune system reset” eliminated autoimmune, or Type 1, diabetes in mice in a study conducted at. Researchers say the strategy could also have potential for treating other autoimmune diseases and ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

T® from the pivotal Precision-T Phase 3 study will be presented including quality of life and rates of rehospitalizations compared to conventional alloHSCTData evaluating the use of Orca-T with ...

ExCellThera and Cordex Biologics’ Zemcelpro receives NUB programme status 1 in Germany: Montreal Tuesday, February 17, 2026, 18:00 Hrs [IST] ExCellThera Inc. (ExCellThera), a gl ...

U.S. Investigational New Drug (IND) applications for radiotheranostic pair PentixaFor and PentixaTher became active following completion of the FDA 30-day review period.Proposed phase I/II trial ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around ...

ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, and its wholly owned subsidiary Cordex Biologics (Cordex), announced that Zemcelpro® (dorocubicel), ...

U.S. Investigational New Drug (IND) applications for radiotheranostic pair PentixaFor and PentixaTher became active following completion of the FDA 30-day review period.Proposed phase I/II trial desig ...

Orsini, a leader in rare disease pharmacy solutions, has been selected by Genetix Biotherapeutics Inc. as a specialty pharmacy partner for three FDA-approved autologous hematopoietic stem cell-based ...

Hospitals are reporting significant success in treating multiple myeloma, with patients undergoing advanced therapies, including second autologous stem cell transplants have exhibited improved ...